@article{article, title = {{The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer}}, publisher = {{Informa UK Limited}}, url = {{https://doi.org/10.1186/s40545-023-00529-0 }}, year = {{2024}}, month = {{3}}, author = {{Sharman Moser S and Tanser F and Siegelmann-Danieli N and Apter L and Chodick G and Solomon J}}, doi = {{10.1186/s40545-023-00529-0}}, volume = {{16}}, journal = {{Journal of Pharmaceutical Policy and Practice}}, issue = {{1}}, pages = {{22}}, note = {{Accessed on 2025/08/22}}}